AIDS 2026 Focuses on Access to HIV Prevention Medicines
2026年愛滋病大會聚焦愛滋病毒預防藥物的獲取
更新於: 2026年7月30日 上午01:15
The 26th International AIDS Conference, AIDS 2026, recently took place in Rio de Janeiro, Brazil, from July 26–31, 2026.
第26屆國際愛滋病大會（AIDS 2026）近期於2026年7月26日至31日在巴西里約熱內盧舉行。
Rise.', the conference addressed a critical moment in the fight against HIV.
與會者強調了一種日益嚴峻的矛盾：儘管這些新工具效力顯著，但資金危機與昂貴的成本意味著它們在許多低收入和中收入國家中仍然難以取得。
While the world has seen remarkable scientific breakthroughs in prevention, such as long-acting injectables like lenacapavir and new once-monthly oral regimens, these advancements face a major implementation hurdle.
包括無國界醫生在內的倡導團體利用該平台敦促藥廠降低價格，以確保全球公平性。
Participants highlighted a growing tension: despite the high efficacy of these new tools, funding crises and high costs mean they remain largely inaccessible in many low- and middle-income countries.
除了藥價之外，大會還強調了將這些創新成果納入現有衛生系統並賦權社區領導組織的必要性。
Advocacy groups, including Doctors Without Borders, used the platform to demand that pharmaceutical companies lower prices and ensure global equity.
隨著新感染率陷入停滯，AIDS 2026 的核心訊息十分明確：科學創新必須與強而有力的取得策略相結合。
Beyond drug prices, the conference emphasized the necessity of integrating these innovations into existing health systems and empowering community-led organizations.
如果不能消除實驗室與最弱勢群體之間的鴻溝，這些醫療奇蹟的潛力將永遠無法實現。
As new infection rates stall, the core message of AIDS 2026 is clear: scientific innovation must be paired with a robust access strategy.
Without bridging the gap between laboratories and the most vulnerable populations, the potential of these medical miracles will remain unfulfilled.
